DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/b63f5e/italy_pharmaceutic) has announced the addition of the "Italy Pharmaceuticals and Healthcare Report Q1 2012" report to their offering.
Business Monitor International's Italy Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Italy's pharmaceuticals and healthcare industry.
BMI View:
Under pressure from jittery financial markets, a new Italian government led by Prime Minister Mario Monti was sworn in on November 16 2011, just four days after the resignation of Silvio Berlusconi. The austerity measures expected in the coming months include the likely reintroduction of the council tax (ICI) on first homes, deep pension reform, a progressive shift in the tax burden away from workers' and corporations' income and towards consumption and wealth, liberalisation of closed professions, privatisations of public utility companies, sale of government-owned real estate and major cuts in politicians' benefits. BMI believes the pharmaceuticals and healthcare sector will be a target of further cost containment - particularly as National Health System (SSN) data for H111, which shows a decline in spending, highlights the success of previous cost-containment efforts.
Key Trends and Developments:
- In September 2011, the European Commission confronted Italy over a marketing authorisation rule for generic drugs in Article 68.1(2) of the Code of Industrial Property.
- In October 2011, Indian drugmaker Ranbaxy Laboratories and Japanese pharmaceutical company Daiichi Sankyo's subsidiaries Ranbaxy Italia and Daiichi Sankyo Italia ormed a partnership to commercialise Daiichi drugs in Italy.
Key Topics Covered:
- SWOT Analysis
- Pharmaceutical Business Environment Ratings
- Industry Forecast Scenario
- Competitive Landscape
- Company Profiles
- Country Snapshot: Italy Demographic Data
Companies Mentioned:
- GlaxoSmithKline
- Menarini
- Merck & Co
- Novartis
- Pfizer
- Recordati
- Sanof
For more information, including full table of contents, please visit http://www.researchandmarkets.com/research/b63f5e/italy_pharmaceutic